(Post-pandemic Era)-Global The Biologic Medication in COVID-19 Market Segment Research Report 2024

Report ID: 874375 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Biologic Medication in COVID-19 Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Biologic Medication in COVID-19 Market by Value
      2.2.1 Global The Biologic Medication in COVID-19 Revenue by Type
      2.2.2 Global The Biologic Medication in COVID-19 Market by Value (%)
    2.3 Global The Biologic Medication in COVID-19 Market by Production
      2.3.1 Global The Biologic Medication in COVID-19 Production by Type
      2.3.2 Global The Biologic Medication in COVID-19 Market by Production (%)

3. The Major Driver of The Biologic Medication in COVID-19 Industry
    3.1 Historical & Forecast Global The Biologic Medication in COVID-19 Demand
    3.2 Largest Application for The Biologic Medication in COVID-19 (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Biologic Medication in COVID-19 Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Biologic Medication in COVID-19 Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Biologic Medication in COVID-19 Average Price Trend
    12.1 Market Price for Each Type of The Biologic Medication in COVID-19 in US (2017-2021)
    12.2 Market Price for Each Type of The Biologic Medication in COVID-19 in Europe (2017-2021)
    12.3 Market Price for Each Type of The Biologic Medication in COVID-19 in China (2017-2021)
    12.4 Market Price for Each Type of The Biologic Medication in COVID-19 in Japan (2017-2021)
    12.5 Market Price for Each Type of The Biologic Medication in COVID-19 in India (2017-2021)
    12.6 Market Price for Each Type of The Biologic Medication in COVID-19 in Korea (2017-2021)
    12.7 Market Price for Each Type of The Biologic Medication in COVID-19 in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Biologic Medication in COVID-19 Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Biologic Medication in COVID-19

14. The Biologic Medication in COVID-19 Competitive Landscape
     14.1 Roche
        14.1.1 Roche Company Profiles
        14.1.2 Roche Product Introduction
        14.1.3 Roche The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Regeneron Pharmaceuticals
        14.2.1 Regeneron Pharmaceuticals Company Profiles
        14.2.2 Regeneron Pharmaceuticals Product Introduction
        14.2.3 Regeneron Pharmaceuticals The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Merck
        14.3.1 Merck Company Profiles
        14.3.2 Merck Product Introduction
        14.3.3 Merck The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Sanofi
        14.4.1 Sanofi Company Profiles
        14.4.2 Sanofi Product Introduction
        14.4.3 Sanofi The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Biogen
        14.5.1 Biogen Company Profiles
        14.5.2 Biogen Product Introduction
        14.5.3 Biogen The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Novartis
        14.6.1 Novartis Company Profiles
        14.6.2 Novartis Product Introduction
        14.6.3 Novartis The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Junshi Biosciences
        14.7.1 Junshi Biosciences Company Profiles
        14.7.2 Junshi Biosciences Product Introduction
        14.7.3 Junshi Biosciences The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Shutaishen
        14.8.1 Shutaishen Company Profiles
        14.8.2 Shutaishen Product Introduction
        14.8.3 Shutaishen The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Bayer
        14.9.1 Bayer Company Profiles
        14.9.2 Bayer Product Introduction
        14.9.3 Bayer The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Vir Biotech
        14.10.1 Vir Biotech Company Profiles
        14.10.2 Vir Biotech Product Introduction
        14.10.3 Vir Biotech The Biologic Medication in COVID-19 Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Anke Biotechnology
     14.12 OncoImmune
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Biologic Medication in COVID-19 Industry (Volume)
    Figure 2. The Biologic Medication in COVID-19 Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Biologic Medication in COVID-19 Revenue in 2021
    Figure 5. US The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Biologic Medication in COVID-19 Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Biologic Medication in COVID-19 Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Biologic Medication in COVID-19 Production, by Type (K Unit) (2017-2027)
    Table 5. The Biologic Medication in COVID-19 Demand (K Unit) by Application (2017-2027)
    Table 6. The Biologic Medication in COVID-19 Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Biologic Medication in COVID-19 Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Biologic Medication in COVID-19 Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Biologic Medication in COVID-19 in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Roche Profiles
    Table 61. Roche The Biologic Medication in COVID-19 Product Introduction
    Table 62. Roche The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Roche Strategic initiatives
    Table 64. Regeneron Pharmaceuticals Profiles
    Table 65. Regeneron Pharmaceuticals The Biologic Medication in COVID-19 Product Introduction
    Table 66. Regeneron Pharmaceuticals The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Regeneron Pharmaceuticals Strategic initiatives
    Table 68. Merck Profiles
    Table 69. Merck The Biologic Medication in COVID-19 Product Introduction
    Table 70. Merck The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Merck Strategic initiatives
    Table 72. Sanofi Profiles
    Table 73. Sanofi The Biologic Medication in COVID-19 Product Introduction
    Table 74. Sanofi The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Sanofi Strategic initiatives
    Table 76. Biogen Profiles
    Table 77. Biogen The Biologic Medication in COVID-19 Product Introduction
    Table 78. Biogen The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Biogen Strategic initiatives
    Table 80. Novartis Profiles
    Table 81. Novartis The Biologic Medication in COVID-19 Product Introduction
    Table 82. Novartis The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Novartis Strategic initiatives
    Table 84. Junshi Biosciences Profiles
    Table 85. Junshi Biosciences The Biologic Medication in COVID-19 Product Introduction
    Table 86. Junshi Biosciences The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Junshi Biosciences Strategic initiatives
    Table 88. Shutaishen Profiles
    Table 89. Shutaishen The Biologic Medication in COVID-19 Product Introduction
    Table 90. Shutaishen The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Shutaishen Strategic initiatives
    Table 92. Bayer Profiles
    Table 93. Bayer The Biologic Medication in COVID-19 Product Introduction
    Table 94. Bayer The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Bayer Strategic initiatives
    Table 97. Vir Biotech Profiles
    Table 98. Vir Biotech The Biologic Medication in COVID-19 Product Introduction
    Table 99. Vir Biotech The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Vir Biotech Strategic initiatives
    Table 101. Anke Biotechnology Profiles
    Table 102. Anke Biotechnology The Biologic Medication in COVID-19 Product Introduction
    Table 103. Anke Biotechnology The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Anke Biotechnology Strategic initiatives
    Table 105. OncoImmune Profiles
    Table 106. OncoImmune The Biologic Medication in COVID-19 Product Introduction
    Table 107. OncoImmune The Biologic Medication in COVID-19 Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Biologic Medication in COVID-19 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Biologic Medication in COVID-19 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Biologic Medication in COVID-19 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports